PhRMA
NOVEMBER 17, 2022
It’s that time of year again: Medicare open enrollment ! Seniors and people with disabilities who are newly eligible for Medicare, as well as current Medicare beneficiaries, can select or update their Part D prescription drug plans for 2023 through Wednesday, December 7. Part D beneficiaries have a variety of plans to choose from, ranging from 24 to 32 options in each state.
Drug Topics
NOVEMBER 17, 2022
New research indicates that gay men are at increased risk of inflammatory bowel disease.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Pharmacy Times
NOVEMBER 17, 2022
Sugar…may not always be sweet. Survivors of childhood cancer have a risk of accelerated aging with every 25 grams of sugar consumed, according to researchers.
Drug Topics
NOVEMBER 17, 2022
Health disparities in care were made worse by the pandemic.
Speaker: Chris Antypas and Josh Halladay
Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.
Pharmacy Times
NOVEMBER 17, 2022
There is at least a 28% difference in the amount of licensed US substance use disorder facilities that accept Medicaid and private insurance compared to Medicare, according to new research.
Drug Topics
NOVEMBER 17, 2022
Experts discuss game-changing drugs and what’s in the pipeline.
Pharmacy Technician Pulse brings together the best content for pharmacy technicians from the widest variety of industry thought leaders.
Drug Topics
NOVEMBER 17, 2022
Insulin glargine-aglr received initial FDA approval in December 2021.
STAT
NOVEMBER 17, 2022
The mystery started with some skin samples. Anura Rambukkana was a Ph.D. student in Amsterdam, analyzing biopsies from migrants with Hansen’s disease, or leprosy. The illness could be painful and disfiguring, but in the lab, the infected cells didn’t look sickly. To Rambukkana’s eye, they seemed to be doing great. He noticed the same thing with nerve cells from mice.
Pharmacy Times
NOVEMBER 17, 2022
Five hours or less hours of sleep per night at 50 years of age was associated with a 25% higher risk of mortality over 25 years of follow-up.
STAT
NOVEMBER 17, 2022
Polio, a dangerous and even deadly infectious disease, is a distant memory for many global citizens. We have never known life without it. Despite growing up in two countries — Pakistan (Z.B.) and Cameroon (R.L.) — separated by 7,000 kilometers, we both know what it is like to live and work in communities plagued by polio. As a physician, one of us (Z.B.) has sat beside countless parents as they come to terms with the life-long disability, and sometimes even death, of their child.
Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist
What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.
pharmaphorum
NOVEMBER 17, 2022
As medical treatments become more complex, the role of the Medical Science Liaison (MSL) has never been more important. Healthcare professionals trust MSLs to keep them informed and up-to-date about the latest treatments, especially in fast-moving areas like oncology. But who keeps the MSLs up-to-date, and who makes sure they have the hard and soft skills necessary to be an effective partner for healthcare professionals?
STAT
NOVEMBER 17, 2022
Editas Medicine, one of the small handful of original CRISPR companies, announced Thursday it is halting development on its first clinical program after data showed only a small subset of patients were responding. Edit-101, an experimental CRISPR-based treatment for a rare eye disease called CEP290-meditated LCA10, led to “clinically meaningful” improvements in sight in only three out of 14 patients treated in the company’s Phase I study.
Drug Topics
NOVEMBER 17, 2022
Jennifer D. Goldman, RPh, PharmD, CDCES, BC-ADM, FCCP, discusses topics to address with patients to ensure appropriate self-administration of insulin.
PharmaVoice
NOVEMBER 17, 2022
The key to a great social media campaign is often simplicity, and these pharma companies hit the nail on the head with unique strategies that aim to educate.
Advertisement
Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.
Drug Topics
NOVEMBER 17, 2022
Drs Meece and Goldman share final thoughts on the overall current and future treatment landscape for diabetes.
Pharmaceutical Technology
NOVEMBER 17, 2022
The National Institute of Health and Care Excellence (NICE) has agreed to update its guidelines on endometriosis diagnosis, surgical management, and surgical management when fertility is a priority. The decision came following a surveillance review led by NICE, which identified sufficient new evidence to support this update. This marks the first update to NICE’s endometriosis guidelines since 2017, representing a huge milestone for patients and practitioners alike.
Drug Topics
NOVEMBER 17, 2022
Segment Description: Addressing fears surrounding insulin injections through education may positively impact treatment adherence.
Fierce Pharma
NOVEMBER 17, 2022
Nothing to sneeze at: AstraZeneca donates thousands of nasal spray flu vaccines after Swiss pricing row. fkansteiner. Thu, 11/17/2022 - 13:27.
STAT
NOVEMBER 17, 2022
NUTLEY, N.J. — A once-in-a-generation medicine was built on more than two decades of regret. In 1997, Eisai launched Aricept, a revolutionary treatment for the symptoms of Alzheimer’s disease, invented and developed by the company’s scientists in Japan. The arrival of the drug was a galvanizing moment for Eisai — a blockbuster product for a company on the rise and the first of what was expected to be a string of medicines to slow or even reverse the effects of the dis
ISPE
NOVEMBER 17, 2022
Artificial Intelligence Used to Optimize Fluid Bed Drying. Trudy Patterson. Thu, 11/17/2022 - 14:11. Online Exclusives. November / December 2022. Artificial Intelligence Used to Optimize Fluid Bed Drying. Roberto Barriga. Matthias Zahn. Rolf Blumenthal. David Zamora, PhD. Miquel Romero Obón. 18 November 2022. This article shows how non-supervised artificial intelligence (AI) methods can strongly support common processes in the pharmaceutical industry such as wet granulation drying.
pharmaphorum
NOVEMBER 17, 2022
In this mini episode of the pharmaphorum podcast, web editor Nicole Raleigh spoke with Sylvana Sinha, founder, chair, and CEO of Praava Health, Bangladesh’s fastest growing healthcare brand. Praava Health is a patient-driven company disrupting the standard of healthcare for Bangladesh’s 170 million citizens. No mean feat. Having heard Sylvana speak with other panellists at Frontiers Health 2022 in Milan, during the Tony Estrella-moderated discussion ‘Beyond video visits: How advanced telehealth
PharmaVoice
NOVEMBER 17, 2022
Artificial intelligence can be a useful tool and will likely augment many processes in biopharma — but it's still early days, and hype is rampant.
pharmaphorum
NOVEMBER 17, 2022
Rising payment percentages under the Voluntary Scheme for Branded Medicines Pricing and Access (VPAS) have been criticised despite (some in) the industry knowing that payment percentages in the range of 30% were not only possible, but predicted. Leela Barham argues that more transparency at a minimum is required next time around, should a VPAS style of agreement be agreed upon for 2024 onwards, and perhaps even a more radical re-think about how a deal is struck in the future.
Drug Store News
NOVEMBER 17, 2022
Genexa's Cough & Chest Congestion for adults is a maximum strength cough suppressant and expectorant designed to temporarily control cough, relieve chest congestion and help thin and loosen mucus.
pharmaphorum
NOVEMBER 17, 2022
At Frontiers Health 2022, pharmaphorum Editor in Chief Jonah Comstock speaks with Sai Shankar and Pierre Leurent, co-presidents of Aptar Digital Health. They discuss their new partnership with Chiesi around disease management for asthma and COPD that was announced at Frontiers Health. Jonah also checks in with Pierre about how the Aptar Pharma – Voluntis acquisition is going one year in and discusses the emergence of the Aptar Digital Health unit that came out of that deal.
European Pharmaceutical Review
NOVEMBER 17, 2022
Final draft guidance published by the National Institute for Health and Care Excellence (NICE), recommends Mobocertinib (Exkivity), a new therapy that helps slow cancer growth in adults with epidermal growth factor receptor ( EGFR ) exon 20+ non-small-cell lung cancer (NSCLC), who have already received platinum-based chemotherapy. The treatment , produced by Takeda helps to addresses a clear unmet clinical need, as there is currently no standard treatment for the disease.
Fierce Healthcare
NOVEMBER 17, 2022
Repeat COVID-19 infection deadlier than the first go-round, says study. fdiamond. Thu, 11/17/2022 - 10:38.
pharmaphorum
NOVEMBER 17, 2022
A proposal in UK chancellor Jeremy Hunt’s autumn statement to overhaul the R&D tax credits system – for small and medium-sized enterprises (SMEs) to reduce what he described as “abuse and fraud” – has been criticised by industry organisations, including the BioIndustry Association (BIA). Hunt said in his address to Parliament today that he plans to cut the deduction rate for the SME scheme to 86% and the credit rate to 10% – from 130% and 14.5% respectively – and increase t
Fierce Healthcare
NOVEMBER 17, 2022
Primary care physician burnout raging across the US and other high-income countries, Commonwealth Fund finds. dmuoio. Thu, 11/17/2022 - 13:03.
Pharmacy Times
NOVEMBER 17, 2022
Students should ask questions and stay engaged in their education.
Fierce Healthcare
NOVEMBER 17, 2022
HLTH22: Private equity rebuffs critics, says it brings rigor, scale and necessary change to healthcare. dmuoio. Thu, 11/17/2022 - 17:57.
European Pharmaceutical Review
NOVEMBER 17, 2022
An innovative ingestible sensor technology tested in an interventional clinical trial provided HIV patients with real-time antiretroviral dosage data , enabling them to better control their infection. The drug regimen for 130 HIV patients was monitored by the Proteus Digital Health Feedback (PDHF) Information Technology system, which let patients know in real-time when a dose of medication had been taken.
pharmaphorum
NOVEMBER 17, 2022
In this episode of the pharmaphorum podcast, Editor in Chief Jonah Comstock chats with Howard Rose, head of health and wellness at Spatial about immersive audio: what it is, how it works, and how it can help in healthcare. Spatial creates immersive soundscape simulations that can be played from any speaker. They do work in the healthcare space, both enlivening healthcare spaces and in delivering therapies.
Drug Store News
NOVEMBER 17, 2022
Drug Store News celebrates the women making their mark in retail pharmacy with the fourth annual awards program.
Expert insights. Personalized for you.
162 
Let's personalize your content